Retraction
Exosomes function as nanoparticles to transfer miR-199a-3p to reverse chemoresistance to cisplatin in hepatocellular carcinoma
Paper Information
Record ID:
37947
Journal:
Publication Date:
July 06, 2020
Retraction Date:
June 27, 2022
(3.4 years years ago)
Subjects:
Institutions:
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Portland Press
Open Access:
Yes
DOI:
PubMed ID:
Retraction PubMed ID:
Retraction Details
Citations (29)
29
Total Citations11
Post-Retraction(37.9%)
18
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
2
Within 30 days
6
Within 1 year
1
After 2+ years
1060
Days since retraction (latest)
Role of extracellular vesicles in cancer: implications in immunotherapeutic resistance
S. Wang, Zerui Wang, Min Liu et al. (4 authors)
Frontiers in Immunology
Open Access
Published: May 2025
1060 days after retraction
Prospects of liquid biopsy in the prognosis and clinical management of gastrointestinal cancers
Deepankar Mondal, Sapnita Shinde, Vibha Sinha et al. (9 authors)
Frontiers in Molecular Biosciences
Open Access
Published: May 2024
6 citations
6 citations
679 days after retraction
Exosomal ncRNAs: Multifunctional contributors to the immunosuppressive tumor microenvironment of hepatocellular carcinoma
Qi Huang, Xin Zhong, Jing Li et al. (8 authors)
Biomedicine & Pharmacotherapy
Open Access
Published: Mar 2024
6 citations
6 citations
620 days after retraction
Combating drug resistance in hepatocellular carcinoma: No awareness today, no action tomorrow
Fanbo Jing, Xiao Li, Hui Jiang et al. (5 authors)
Biomedicine & Pharmacotherapy
Open Access
Published: Sep 2023
6 citations
6 citations
455 days after retraction
HBx promotes tumorigenicity through RRM2-mediated autophagy in hepatocellular carcinoma
Bin Wang, li yaqun, Furan Wang et al. (7 authors)
Research Square (Research Square)
Open Access
Published: Aug 2023
400 days after retraction
Targeted delivery of RNAi to cancer cells using RNA-ligand displaying exosome
Nasir Uddin, Daniel W. Binzel, Dan Shu et al. (5 authors)
Acta Pharmaceutica Sinica B
Open Access
Published: Nov 2022
36 citations
36 citations
143 days after retraction
Overcoming the therapeutic resistance of hepatomas by targeting the tumor microenvironment
Jiaxin Zhang, Huiqiong Han, Lei Wang et al. (6 authors)
Frontiers in Oncology
Open Access
Published: Nov 2022
7 citations
7 citations
141 days after retraction
Non-coding RNAs in hepatocellular carcinoma: Insights into regulatory mechanisms, clinical significance, and therapeutic potential
Han Qin, Mengchen Wang, Xi Dong et al. (6 authors)
Frontiers in Immunology
Open Access
Published: Oct 2022
24 citations
24 citations
105 days after retraction
Exosomal Non-Coding RNAs: New Insights into the Biology of Hepatocellular Carcinoma
Qian Zhang, Hanlin Li, Yang Liu et al. (6 authors)
Current Oncology
Open Access
Published: Jul 2022
39 citations
39 citations
32 days after retraction
Role of exosomal microRNAs in cancer therapy and drug resistance mechanisms: focus on hepatocellular carcinoma
Veronica Zelli, Chiara Compagnoni, Roberta Capelli et al. (8 authors)
Frontiers in Oncology
Open Access
Published: Jul 2022
15 citations
15 citations
18 days after retraction
Emerging role of exosomes in cancer progression and tumor microenvironment remodeling
Mahshid Deldar Abad Paskeh, Maliheh Entezari, Sepideh Mirzaei et al. (19 authors)
Journal of Hematology & Oncology
Open Access
Published: Jun 2022
405 citations
405 citations
1 days after retraction
Recent advances in exosome-mediated nucleic acid delivery for cancer therapy
Ying Zhang, Qiqi Liu, Xinmeng Zhang et al. (11 authors)
Journal of Nanobiotechnology
Open Access
Published: Jun 2022
215 citations
215 citations
13 days before retraction
<scp>miRNAs</scp> are now starring in “<i>No Time to Die</i>: Overcoming the chemoresistance in cancer”
Anmol Bhatia, Atul Kumar Upadhyay, Siddharth Sharma
IUBMB Life
Published: Jun 2022
3 citations
3 citations
18 days before retraction
Extracellular Vesicle-Mediated Mitochondrial Reprogramming in Cancer
Roger Carles-Fontana, Nigel Heaton, Elena Palma et al. (4 authors)
Cancers
Open Access
Published: Apr 2022
14 citations
14 citations
81 days before retraction
Current Perspectives on the Unique Roles of Exosomes in Drug Resistance of Hepatocellular Carcinoma
Dongdong Xue, Jingzhao Han, Ze Liang et al. (7 authors)
Journal of Hepatocellular Carcinoma
Open Access
Published: Feb 2022
18 citations
18 citations
146 days before retraction
Role of Exosomes in Immune Microenvironment of Hepatocellular Carcinoma
Xiaojing Chen, Hao Chi, Xiaozhao Zhao et al. (6 authors)
Journal of Oncology
Open Access
Published: Jan 2022
29 citations
29 citations
150 days before retraction
Gastrointestinal cancer drug resistance: the role of exosomal miRNAs
Mahsa Salehi, Asma Vafadar, Seyyed Hossein Khatami et al. (11 authors)
Molecular Biology Reports
Published: Nov 2021
25 citations
25 citations
209 days before retraction
New Hope for Intervertebral Disc Degeneration: Bone Marrow Mesenchymal Stem Cells and Exosomes Derived from Bone Marrow Mesenchymal Stem Cell Transplantation
Xiaobo Zhang, Xiangyi Chen, Jin Qi et al. (11 authors)
Current Gene Therapy
Published: Oct 2021
11 citations
11 citations
255 days before retraction
Rno-miR-199a-3p targets Nedd4 to promote sensitization of ST36 acupoints via mast cell activation in a rat model of knee osteoarthritis
Wenchuan Qi, Baitong Liu, Yilu Jiang et al. (8 authors)
Research Square (Research Square)
Open Access
Published: Oct 2021
258 days before retraction
Exosome encapsulated ncRNAs in the development of HCC: potential circulatory biomarkers and clinical therapeutic targets.
Mingyuan Wang, Yutong Wang, Ye Fan et al. (8 authors)
Unknown Journal
Published: Aug 2021
8 citations
8 citations
316 days before retraction
Exosomal Noncoding RNAs in Hepatobiliary Cancer: A Rising Star
Wangyang Zheng, Daolin Ji, Yongxu Zhou et al. (14 authors)
Molecular Cancer Therapeutics
Open Access
Published: Aug 2021
3 citations
3 citations
321 days before retraction
Exosomal microRNAs in hepatocellular carcinoma
Chenbin Liu, Han Wu, Yinqi Mao et al. (5 authors)
Cancer Cell International
Open Access
Published: May 2021
15 citations
15 citations
415 days before retraction
Current perspectives on exosomes in the diagnosis and treatment of hepatocellular carcinoma (review)
Dongdong Xue, Jingzhao Han, Yifan Liu et al. (5 authors)
Cancer Biology & Therapy
Open Access
Published: Apr 2021
14 citations
14 citations
450 days before retraction
Exosomal Non-Coding RNAs: Regulatory and Therapeutic Target of Hepatocellular Carcinoma
Haoming Xia, Ziyue Huang, Shuqiang Liu et al. (16 authors)
Frontiers in Oncology
Open Access
Published: Mar 2021
4 citations
4 citations
458 days before retraction
Expedition into Exosome Biology: A Perspective of Progress from Discovery to Therapeutic Development
Arif Tasleem Jan, Safikur Rahman, Raied Badierah et al. (7 authors)
Cancers
Open Access
Published: Mar 2021
36 citations
36 citations
476 days before retraction
Exosome in Hepatocellular Carcinoma: an update
Wei Chen, Yinqi Mao, Chenbin Liu et al. (5 authors)
Journal of Cancer
Open Access
Published: Jan 2021
38 citations
38 citations
542 days before retraction
Exosomes in osteosarcoma research and preclinical practice.
Xiaobo Zhang, Ruihao Zhang, Xin Su et al. (9 authors)
Unknown Journal
Published: Jan 2021
14 citations
14 citations
542 days before retraction
Exosomal noncoding RNAs in cholangiocarcinoma: Laboratory noise or hope?
Konstantinos Laschos, Dimitra Ioanna Lampropoulou, Gerasimos Aravantinos et al. (7 authors)
World Journal of Gastrointestinal Surgery
Open Access
Published: Oct 2020
7 citations
7 citations
608 days before retraction
Recent Advances in Extracellular Vesicles as Drug Delivery Systems and Their Potential in Precision Medicine
Bart de Jong, Eric Barros, Joost G.J. Hoenderop et al. (4 authors)
Pharmaceutics
Open Access
Published: Oct 2020
53 citations
53 citations
613 days before retraction
Related Records
This article has multiple records in the database due to different notices:
Record #37948
Jun 14, 2022Quick Stats
Total Citations:
29
Years Since Retraction:
3.4 years
Open Access:
Yes
Last Checked:
Jul 24, 2025